Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
43 patents granted to the 5 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Abeona Therapeutics Inc.’s names, not what it holds today.
Patents granted
43
43 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against 1 in 2024 and none in 2023
Applications published
17
2 of them in 2025
Names they are printed under
5
a former name, a subsidiary, its own name
By yearGrantedApplications published
'01'02'03'04'06'07'09'10'11'12'16'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name5 counted
Access Pharmaceuticals, Inc. a former name
US, as the owner printed on each patent
6 publishedMacroChem Corporation a subsidiary
US, as the owner printed on each patent
3 publishedChemex Pharmaceuticals, Inc. a former name
US, as the owner printed on each patent
0 publishedAbeona Therapeutics Inc. its own name
named as the applicant on its applications, in US
7 publishedAbeona Therapeutics Inc. its own name
US, as the owner printed on each patent
1 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Oct 28, 2025 | 12,454,701 | Recombinant adeno-associated viral vector for gene delivery | Biotechnology | Abeona Therapeutics Inc. |
| Nov 19, 2024 | 12,144,340 | Devices, systems, and methods for packaging and transport of biological tissue | Handling | Abeona Therapeutics Inc. |
| Jul 13, 2010 | 7,754,684 | Macromolecular platinum chelates | Organic fine chemistry | Access Pharmaceuticals, Inc. |
| Jun 16, 2009 | 7,547,433 | Liquid formulations for the prevention and treatment of mucosal diseases and disorders | Pharmaceuticals | Access Pharmaceuticals, Inc. |
| Jun 9, 2009 | 7,544,348 | Liquid formulations for the prevention and treatment of mucosal diseases and disorders | Pharmaceuticals | Access Pharmaceuticals, Inc. |
| Jan 23, 2007 | 7,166,733 | O,O'-Amidomalonate and N,O-Amidomalonate platinum complexes | Pharmaceuticals | Access Pharmaceuticals, Inc. |
| Feb 17, 2004 | 6,692,734 | N,O-amidomalonate platinum complexes | Pharmaceuticals | Access Pharmaceuticals, Inc. |
| Jul 1, 2003 | 6,585,997 | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds | Pharmaceuticals | Access Pharmaceuticals, Inc. |
| Feb 18, 2003 | 6,521,431 | Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments | Organic fine chemistry | Access Pharmaceuticals, Inc. |
| Dec 17, 2002 | 6,495,124 | Antifungal nail lacquer and method using same | Pharmaceuticals | MacroChem Corporation |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Aug 21, 2025 | 2025/0262327 | COMPOSITIONS AND METHODS FOR TREATING DOMINANT OPTIC ATROPHY AND X-LINKED RETINOSCHISIS | Pharmaceuticals | Abeona Therapeutics Inc. |
| Jan 23, 2025 | 2025/0024833 | DEVICES, SYSTEMS, AND METHODS FOR PACKAGING AND TRANSPORT OF BIOLOGICAL TISSUE | Handling | Abeona Therapeutics Inc. |
| Aug 15, 2024 | 2024/0269326 | METHODS AND COMPOSITIONS FOR TREATING OCULAR DISEASES AND DISORDERS | Pharmaceuticals | Abeona Therapeutics Inc. |
| Sep 14, 2023 | 2023/0287458 | RECOMBINANT ADENO-ASSOCIATED VIRAL VECTORS FOR MULTIPARTITE GENE DELIVERY | Biotechnology | Abeona Therapeutics Inc. |
| Sep 22, 2022 | 2022/0295783 | DEVICES, SYSTEMS, AND METHODS FOR PACKAGING AND TRANSPORT OF BIOLOGICAL TISSUE | Handling | Abeona Therapeutics Inc. · patent 12,144,340 granted from it |
| Jun 23, 2022 | 2022/0193268 | INTRATHECAL AND INTRAVENOUS COMBINATION GENE THERAPY FOR THE TREATMENT OF INFANTILE BATTEN DISEASE | Pharmaceuticals | Abeona Therapeutics Inc. |
| Mar 24, 2022 | 2022/0090129 | RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR FOR GENE DELIVERY | Biotechnology | Abeona Therapeutics Inc. · patent 12,454,701 granted from it |
| Jun 23, 2016 | 2016/0175259 | Targeted Nanocarrier Systems for Delivery of Actives Across Biological Membranes | Pharmaceuticals | Abeona Therapeutics Inc. |
| Sep 13, 2012 | 2012/0231069 | Targeted Nanocarrier Systems for Delivery of Actives Across Biological Membranes | Pharmaceuticals | Access Pharmaceuticals, Inc. |
| Nov 24, 2011 | 2011/0286958 | HPMA POLYMER PLATINUM CHELATES | Pharmaceuticals | Access Pharmaceuticals, Inc. |
What it applied for, 2024 to 2025: Pharmaceuticals 2 · Handling 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.